StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

Seaport Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Seaport Therapeutics's total assets was $417.62M at Sep 30, 2026. For fiscal 2025 it was $249.01M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$249.01M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$417.62M–
Q2 FY2026Jun 30, 2026$441.68M–
Q1 FY2026Mar 31, 2026$227.67M–
Q4 FY2025Dec 31, 2025$249.01M–

More Seaport Therapeutics figures

See a number that looks wrong?